Proton magnetic resonance spectroscopy predicts radiotherapy response and time-to-progression in high-grade gliomas after surgery

被引:0
|
作者
QU Jin-rong [1 ]
JIANG Tao [2 ]
DAI Jian-ping [1 ]
LI Hai-liang [3 ]
LUO Jun-peng [3 ]
LI Shao-wu [1 ]
AI Lin [1 ]
JIANG Tian-zi [4 ]
机构
[1] Department of Neuroradiology,Beijing Tiantan Hospital,Capital Medical University
[2] Department of Neurosurgery,Beijing Tiantan Hospital,Capital Medical University
[3] Department of Radiology,Affiliated Cancer Hospital,Zhengzhou University
[4] Institute of Automation Chinese Academy of Sciences
基金
中国国家自然科学基金;
关键词
D O I
暂无
中图分类号
R739.4 [神经系肿瘤];
学科分类号
摘要
Background Reliable early prediction response to therapy and time-to-progression(TTP) remain an important goal of high-grade gliomas(HGGs) research.Proton magnetic resonance spectroscopy(H-MRS) has been applied with variable success in clinical application,and we hypothesize thatH-MRS in predictive value should perform well as a marker of TTP in patients treated with radiotherapy(RT) after surgery. MethodsH-MRS was performed before surgery on 25 patients who had undergone resection of HGGs;then the ratios of lipid/creatine(Lip/Cr) and myo-inositol/creatine(ml/Cr) were determined in the solid tumor.RT response was classified as follows:complete resolution(CR),partial response(PR),stable disease(SD),and progressive disease(PD) by comparison of pre-treatment and post-radiotherapy scans.TTP was defined at the time to radiographic progression by MacDonald criteria.Correlation was evaluated between the ratios of Lip/Cr,ml/Cr and treatment response,TTP.The chi-square test and Pearson correlation test were used for data analyses. Results Multivariate analysis revealed that the prognostic value of spectroscopic variables was independent of age, sex,WHO histologic grade,extent of surgery,and Karnofsky score(KPS).The correlation between the ratios of lipid/Cr and TTP was significant(r=0.894,P=0.000),and between the ratios of ml/Cr and TTP was also significant(r=0.891, P=0.000).As predicted,RT response correlated significantly with TTP(r=0.59,P=0.002):median TTP was 49.9 days for patients with PD compared with 202.7 days for SD,208.0 days for PR,and 234.5 days for CR. Conclusion The ratios of Lip/Cr and ml/Cr of the solid tumor region before surgery could provide important information in predicting RT response and TTP in patients with HGGs treated by radiation alone after surgery.
引用
收藏
页码:4334 / 4337
相关论文
共 50 条
  • [41] Intracranial blastomycosis mimicking high-grade neoplasm on magnetic resonance imaging and spectroscopy
    Baruah, Dhiraj
    Guleria, Saurabh
    Michel, Michelle A.
    Gill, Sonia
    INDIAN JOURNAL OF NEUROSURGERY, 2013, 2 (01) : 87 - 88
  • [42] Differentiation of High-Grade and Low-Grade Gliomas Using Pattern Analysis of Long-Echo Single-Voxel Proton Magnetic Resonance Spectroscopy (1H-MRS)
    Chernov, M. F.
    Ono, Y.
    Muragaki, Y.
    Kubo, O.
    Nakamura, R.
    Iseki, H.
    Hori, T.
    Takakura, K.
    NEURORADIOLOGY JOURNAL, 2008, 21 (03): : 338 - 349
  • [43] Patterns of tumor progression after radiotherapy for low-grade gliomas - Analysis from the computed tomography magnetic resonance imaging era
    Rudoler, S
    Corn, BW
    Werner-Wasik, M
    Flanders, A
    Preston, PE
    Tupchong, L
    Curran, WJ
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (01): : 23 - 27
  • [44] Integration of 11C-methionine (MET) PET and magnetic resonance (MR) for radiotherapy target definition of high-grade gliomas (HGG)
    Rodari, Marcello
    Greco, Marcella
    Navarria, Piera
    Rossi, Pietro
    Lattuada, Paola
    Vaccaro, Ilaria
    Scorsetti, Marta
    Chiti, Arturo
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [45] MGMT promoter methylation is a strong prognostic factor for survival after progression in high-grade gliomas
    Jing Zhang
    Xiaoguang Qiu
    Jin Feng
    Yanwei Liu
    Chinese Neurosurgical Journal, 10 (1)
  • [46] MGMT promoter methylation is a strong prognostic factor for survival after progression in high-grade gliomas
    Zhang Jing
    Qiu Xiaoguang
    Feng Jin
    Yanwei Liu
    中华神经外科杂志(英文), 2024, 10 (03)
  • [47] Integration of Diffusion Magnetic Resonance Tractography into tomotherapy radiation treatment planning for high-grade gliomas
    Altabella, Luisa
    Broggi, Sara
    Mangili, Paola
    Conte, Gian Marco
    Pieri, Valentina
    Iadanza, Antonella
    del Vecchio, Antonella
    Anzalone, Nicoletta
    di Muzio, Nadia
    Calandrino, Riccardo
    Falini, Andrea
    Castellano, Antonella
    PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2018, 55 : 127 - 134
  • [48] Dose-Painting Proton Radiotherapy Guided by Functional MRI in Non-enhancing High-Grade Gliomas
    Zhu, Z.
    Gong, G.
    Wang, L.
    Su, Y.
    Lu, J.
    Dong, G.
    Yin, Y.
    CLINICAL ONCOLOGY, 2024, 36 (09) : 552 - 561
  • [49] Intraoperative Magnetic Resonance Imaging for Low-Grade and High-Grade Gliomas: What Is the Evidence? A Meta-Analysis
    Lo, Yu Tung
    Lee, Hyunkyung
    Shui, Cher
    Lamba, Nayan
    Korde, Rasika
    Devi, Sharmila
    Chawla, Shreya
    Nam, Younjong
    Patel, Romel
    Doucette, Joanne
    Bunevicius, Adomas
    Mekary, Rania A.
    WORLD NEUROSURGERY, 2021, 149 : 232 - +
  • [50] Phase II trial of erlotinib during and after radiotherapy in children with newly diagnosed high-grade gliomas
    Qaddoumi, Ibrahim
    Kocak, Mehmet
    Panandiker, Atmaram S. Pai
    Armstrong, GregoryT
    Wetmore, Cynthia
    Crawford, John R.
    Lin, Tong
    Boyett, James M.
    Kun, Larry E.
    Boop, Fredrick A.
    Merchant, Thomas E.
    Ellison, David W.
    Gajjar, Amar
    Broniscer, Alberto
    FRONTIERS IN ONCOLOGY, 2014, 4